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Summary
Objective: We have previously shown that microfractured ovine defects are repaired with more hyaline cartilage when the defect is treated with
in situ-solidiﬁed implants of chitosaneglycerol phosphate (chitosaneGP) mixed with autologous whole blood. The objectives of this study were
(1) to characterize chitosaneGP/blood clots in vitro, and (2) to develop a rabbit marrow stimulation model in order to determine the effects of
the chitosaneGP/blood implant and of debridement on the formation of incipient cartilage repair tissue.
Methods: Blood clots were characterized by histology and in vitro clot retraction tests. Bilateral 3.5 4 mm trochlear defects debrided into the
calciﬁed layer were pierced with four microdrill holes and ﬁlled with a chitosaneGP/blood implant or allowed to bleed freely as a control. At 1
day post-surgery, initial defects were characterized by histomorphometry (n¼ 3). After 8 weeks of repair, osteochondral repair tissues
between or through the drill holes were evaluated by histology, histomorphometry, collagen type II expression, and stereology (n¼ 16).
Results: ChitosaneGP solutions structurally stabilized the blood clots by inhibiting clot retraction. Treatment of drilled defects with chitosane
GP/blood clots led to the formation of a more integrated and hyaline repair tissue above a more porous and vascularized subchondral bone
plate compared to drilling alone. Correlation analysis of repair tissue between the drill holes revealed that the absence of calciﬁed cartilage and
the presence of a porous subchondral bone plate were predictors of greater repair tissue integration with subchondral bone (P< 0.005), and of
a higher total O’Driscoll score (P< 0.005 and P< 0.01, respectively).
Conclusions: ChitosaneGP/blood implants applied in conjunction with drilling, compared to drilling alone, elicited a more hyaline and inte-
grated repair tissue associated with a porous subchondral bone replete with blood vessels. Concomitant regeneration of a vascularized
bone plate during cartilage repair could provide progenitors, anabolic factors and nutrients that aid in the formation of hyaline cartilage.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Partial thickness cartilage lesions fail to heal and often lead
to further degeneration and joint disease1. Focal cartilage
lesions can be resurfaced in human patients2e4 and in
experimental defects in animals5e10 when residual cartilage
is removed, and access to the vascularized bone marrow
provided through abrasion arthroplasty, or debridement
and microfracture or drilling2e4. However, in both patients11
and animal models5e10, the resulting repair tissue is
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Received 7 February 2006; revision accepted 25 June 2006.78typically ﬁbrocartilaginous or ﬁbrous, tissue types known
to have weak biomechanical properties and reduced wear
capacity compared to hyaline cartilage, which contains
high levels of collagen type II and glycosaminoglycans
(GAG)5,12. Bone marrow-derived repair cells can give rise
to a degree of cartilaginous repair tissue in young rab-
bits7,12,13, however, this repair occurs only sporadically in
adult rabbits5e7. Repair processes, which reliably lead to
hyaline cartilage regeneration and integration in skeletally
mature defects have yet to be elucidated.
Since bleeding has been identiﬁed as an initiating event in
post-surgical repair2e4, we hypothesized that microfracture-
based repair could be improved by stabilizing the clot formed
in the lesion with a polymer that is thrombogenic and actively
stimulates the wound repair process. Chitosan is a positively
charged polymer composed of (1/ 4)-b-linked glucos-
amine and acetyl-glucosamine residues. Previous studies
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in the wound site, stimulates revascularization of the
wound14 and connective tissue repair14,18e20. Chitosan is
also biodegradable17,21,22, non-immunogenic23,24, and ad-
heres to connective tissues including cornea, bone, and car-
tilage25,26. We discovered a means of solubilizing chitosan
under physiological conditions by combining it with glycerol
phosphate to form chitosaneglycerol phosphate (chitosa-
neGP) solutions27e29. And in a recent study we showed
that mixtures of whole blood with chitosaneGP could form
solid implants above microfractured cartilage defects26.
These implants adhered more to the defect than normal
clots, and elicited signiﬁcantly more hyaline repair compared
to microfracture alone in an ovine model at 6 months26.
In the study presented here, we describe the develop-
ment of a bilateral rabbit cartilage repair model to efﬁciently
screen implants for their ability to improve repair of marrow-
stimulated defects as well as to elucidate mechanisms of
action. This model was used to test the hypothesis that
hyaline cartilage repair after marrow stimulation depends
upon the surgical approach and the use of chitosaneGP/
blood implants. ChitosaneGP stabilized blood clots were
made by combining chitosaneGP solutions with peripheral
whole blood from human volunteers, or with blood from two
distinct animal species used in cartilage repair studies, rab-
bit and sheep. Our surgical model was based on a rabbit
model previously published by Mitchell and Shepard6, rep-
resenting a scaled-down version of human lesions that
are treated by microfracture or drilling. This is in contrast
to other rabbit models where repair was observed over
single, large osteochondral drill holes13,30,31 which do not
mimic human lesions. The generation of rectangular troch-
lear defects with precisely placed drill holes also permitted
us to analyze the effect of treatment on repair tissue formed
directly over the drill holes, compared to repair tissue
formed over the defect surface between the drill holes.
Methods
MATERIALS
Ultrapure chitosan was obtained from BioSyntech (77.1%
degree of deacetylation (DDA), <375 endotoxin units (EU)/
g; 79% DDA, <3000 EU/g; 83.4% DDA, <500 EU/g free
base from Laval, QC, Canada) or Pronova (84.5% DDA,
130 EU/g, HCl salt from Oslo, Norway). BioSyntech chito-
san was dissolved at 1.66% w/v or at 1.89% w/v (taking
into account loss on drying) in 60 mM to 83 mM HCl and au-
toclave-sterilized. Pronova chitosan was lyophilized,
weighed, sterilized by exposing the powder to UV light for
90 min, and then dissolved in sterile MilliQ-ﬁltered water
at 1.66% w/v, taking into account HCl salt content. Sterile
chitosan solutions were combined with ﬁlter-sterilized diso-
dium beta-glycerol phosphate (Tissue Culture grade,
Sigma, St. Louis, MO) to yield transparent solutions with
1.5% w/v or 1.7% w/v chitosan with 135 mM glycerol phos-
phate (also called BST-CarGel), pH 6.8, osmolality of
470 mOsm, and viscosity of 250e1100 mPa s at 25C,
that were stored at 80C.
BLOOD COLLECTION AND CHITOSANeGP/BLOOD MIXTURES
All protocols involving animals were approved by institu-
tional animal care committees and all protocols involving
human subjects were approved by an Internal Review
Board Ethical Committee. Peripheral whole blood wascollected aseptically from the central ear artery from 15
New Zealand White rabbits with atravet or ketamine/xyla-
zine/buprenorphine and isoﬂurane gas anesthesia and the
jugular vein of 10 sheep with or without ketamine/diazepam
and halothane gas anesthesia. Anesthetics can affect plate-
let function32, however, whole blood clotting times from
anesthetized animals and unanesthetized humans were
similar to published values33. Venous blood was collected
aseptically from non-fasting healthy volunteers (n¼ 7,
23e43 years old). Non-activated whole blood was drawn
into plastic syringes after a 2 mL ﬁrst discard, with a
21-gauge 3/4 inch butterﬂy needle with female luer and out-
let needle. Homogeneous aseptic mixtures were obtained
by ﬁlling 4.0 mL Wheaton glass vials with plastic screw-
caps to capacity with 1.1 mL chitosaneGP solution,
3.3 mL fresh blood, and six surgical 316 stainless steel mix-
ing beads (4.5 mm diameter, Salem Specialty, Canton, CT),
closing the vials, and shaking vigorously for 10 s.
BLOOD SMEARS, CLOTTING TIME, CLOT RETRACTION,
AND HEMOLYSIS MEASUREMENTS
Blood smears were generated with blood or chitosaneGP/
blood mixtures within 3 min after mixing and stained with
May Grunwald Geimsa (Sigma, St. Louis, MO). Clotting
time was measured using the LeeeWhite clotting test in
dry, sterile, non-siliconized glass tubes with vented steel
caps and 0.5 mL sample volumes34. Tubes containing
0.5 mL solid clot samples were transferred to a humidiﬁed
37C incubator for 4 h to determine percent retraction by
weighing separately the excluded serum and mass of the
solid clot. Hemolysis was determined by serum hemoglo-
bin absorbance at OD530 using an enzyme-linked immu-
nosorbent assay (ELISA) plate reader, modiﬁed from
a previous method35.
FEASIBILITY STUDIES
To test the effect of removal of the calciﬁed cartilage layer
on repair with or without implant, bilateral defects were cre-
ated identically in each trochlear groove in the knees of
skeletally mature rabbits. In three rabbits, defects were de-
brided into, but not beyond, the calciﬁed cartilage while in
another three rabbits, bilateral defects were completely de-
brided of the calciﬁed layer to bleeding cancellous bone. All
defects were then pierced with four or ﬁve, 0.9 mm diameter
3 mm deep holes with either a drill bit or a custom-made
pick and hammer. ChitosaneGP/blood implant was solidi-
ﬁed in one defect while the contralateral defect was allowed
to bleed as a surgical control. Defects were allowed to
repair for 7e11 weeks then ﬁxed, decalciﬁed, processed
in LR White plastic resin, stained with Toluidine Blue and
analyzed histologically.
RABBIT CARTILAGE REPAIR MODEL
Thirty-eight bilateral defects were created in the knees of
19 skeletally mature New Zealand White rabbits (9e15
month old females, 4.6 0.8 kg, Table I). Three of these
rabbits were used to evaluate the initially debrided defects
at 1 day post-op while defects in the remaining 16 rabbits
were evaluated at 8 weeks post-op. Rabbits were anesthe-
tized by an intramuscular injection of ketamine/xylazine/
buprenorphine, and maintained on 3% isoﬂurane/oxygen.
The ears (phlebotomy site) and legs were shaved and
disinfected with Baxedin, poviodine, and 70% ethanol.
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ing sequential bilateral arthrotomies with a medial parapa-
tellar incision followed by patellar luxation. Joint surfaces
were kept moist with sterile phosphate buffered saline
(PBS) irrigation every 30e60 s to maintain viability of cells
in the exposed articular and calciﬁed cartilages. Chondral
defects (3.5 4 mm) were made in the center of the troch-
lear groove to a depth of around 200 mm, 3e5 mm above
the lateral collateral ligament insertion, by scraping with
1.5e2.75 mm ﬂat surgical blades (Fine Science Tools,
North Vancouver, B.C., Canada) into the calciﬁed cartilage.
Four, 3e4 mm deep microdrill holes were then generated in
each of the corners of the defect using a high-speed, hand-
held microdrill and 0.9 mm diameter drill bit (Fine Science
Tools, North Vancouver, B.C., Canada) with constant 4C
PBS irrigation to avoid thermal necrosis and to wash
away bone debris. Bleeding from subchondral holes, which
was minimal in >10 month old rabbits, was additionally pro-
moted by inserting a 26-gauge 1/2 inch needle into each
hole. Once the defects were hemostatic, freshly drawn
whole blood was mixed with chitosaneGP (79% DDA chito-
san), drawn into a 1 cc syringe with a 20-gauge needle, and
one drop (w25 mL) deposited directly onto the horizontally
held defect within 2 min of mixing where the implant solidi-
ﬁed within 7e9 min. These w25 mL implants were larger
than the 3.5 4 0.2 mm chondral defect volume
(w2.8 mL), and completely covered the defect. Defects
were treated with chitosaneGP/blood in alternating right
and left knees (Table I). Contralateral defects were allowed
to ﬁll with bone-derived blood without further intervention,
as in standard drilling procedures2 and served as controls.
The patella was repositioned and the knee closed in su-
tured layers. Animals were allowed immediate unrestrained
activity in cages after recovery from anesthesia, and re-
ceived buprenorphine anti-pain medication twice daily for
3 days following arthrotomy. No antibiotics were given. All
joints at sacriﬁce were free from infection, and at necropsy
rabbits had neither effusions nor weight loss. Eight out of
the 16 rabbits were housed in free-range enclosures
(2.6 2.7 m) prior to surgery and for the ﬁnal 4e6 weeks
of the 8 week repair period while all other rabbits were
housed in cages (0.6 0.6 0.4 m, lengthewidtheheight)
for the entire repair period.
HISTOPROCESSING AND IMMUNOHISTOCHEMISTRY
All clot samples were ﬁxed after 1e4 h post-solidiﬁcation
in 4% glutaraldehyde/PBS or 10% buffered formalin and
then either processed in LR White plastic resin and stained
with Toluidine Blue, or processed in parafﬁn and stained
with Safranin O/Fast Green/Iron Hematoxylin to identify
chitosan by speciﬁc Fast Green-speciﬁc staining character-
istics36. Immediately after sacriﬁce, distal femora were re-
covered, dissected of all soft tissues and ﬁxed for 3 days
in 4% paraformaldehyde/1% glutaraldehyde/100 mM
sodium cacodylate, pH 7.2. Defects from 1 day post-op
were decalciﬁed in ethylenediaminetetraacetic acid (EDTA),
Table I
Rabbit cartilage repair study design
Number of
animals
Treated
defects
Control
defects
Repair
period
N¼ 3 N¼ 3 (right knee) N¼ 3 (left knee) 1 day
N¼ 16 N¼ 8 (right knee) N¼ 8 (left knee) 8 weeks
N¼ 8 (left knee) N¼ 8 (right knee)and cryosections generated from the middle of each
defect and stained with Safranin O/Fast Green. Defects
after 8 weeks of repair were decalciﬁed in 0.5 M HCl/0.1%
glutaraldehyde for 7e10 days then trimmed and bisected
transversely with a razor between the drill holes. The prox-
imal defect half was embedded in LR White plastic resin,
while the distal half was embedded in parafﬁn. Five to 20,
1 mm-thick plastic sections were generated in the proximal
half of the repaired defects, including between the drill
holes, within the drill holes, and proximal to the drill holes
and stained with Toluidine Blue. Parafﬁn sections 6 mm
thick were generated from the distal half within the drill
holes, then dewaxed, digested with 2.5% w/v hyaluronidase
and processed by immunohistochemistry as previously
described37 for collagen type II using monoclonal II-II6B3
(DSHB, Iowa, USA) at 1:10 dilution, biotinylated goat anti-
mouse diluted to 22 mg/mL, and avidin-Alkaline Phospha-
tase-red substrate detection (Vector Laboratories Inc.,
Burlington, Ontario, Canada), followed by light Iron Hema-
toxylin counterstain. Control isotype antibody or omission
of primary antibody showed no staining.
QUALITATIVE HISTOLOGICAL SCORING AND QUANTITATIVE
HISTOMORPHOMETRY
Four to 12 sections from distinct areas within the proximal
half of each defect were graded by a blinded observer using
the O’Driscoll score31, with the exception that staining inten-
sity was determined with Toluidine Blue instead of Alcian
Blue. The score for normal cartilage is 2431. This evaluation
revealed that the edge of the ‘‘tufts’’ of repair tissue covering
the drill holes contained less differentiated cells than the cen-
ter of the tufts, as previously reported by Mitchell and She-
pard6. Therefore, one section in the middle of the holes
and one section between the holes were selected from
each defect to compare O’Driscoll scores. All histomorpho-
metric and stereologic analyses were performed on these
same two plastic-embedded sections by a blinded observer,
using a Zeiss Axiovert microscope, digital camera, and his-
tomorphometric software (Northern Eclipse, Empix Imaging,
Mississauga, ON) to measure the width of the cross-section
of each defect, the percent of different tissues covering the
defect (repair tissue, bone or calciﬁed cartilage), and the per-
cent of repair tissue clearly detached from the base of the
defect. The same histomorphometric analysis for percent of
different tissues covering the initial defects was performed
on one section from the middle of each defect after 1 day
of repair (n¼ 3 sections per condition). In sections from de-
fects repaired for 8 weeks, percent of integrated repair tissue
was determined as the total length of the repair tissue at-
tached to the defect base divided by the defect width. Repair
tissue area was determined as the cross-sectional area of
tissues above subchondral bone, excluding bone, and ex-
cluding soft tissues occasionally present in the drill holes.
Collagen type II staining in repair tissue above the subchon-
dral bone was quantiﬁed by threshold analysis as the per-
cent of total repair tissue area that stained pink and light
red, vs a dark red hue that matched the staining intensity
of normal cartilage37.
For stereology measurements, digital print-outs were
generated of a segment of subchondral bone directly be-
neath the repair tissue (250 mm deep, the entire width of
the defect) to measure bone porosity. Histologically identi-
ﬁed pores were traced with a line tool to render them
more visible. A grid with 19.75 mm 19.75 mm squares
was randomly positioned over the sample image and the
number of intersections (I ) of grid lines with the surfaces
81Osteoarthritis and Cartilage Vol. 15, No. 1Fig. 1. ChitosaneGP/blood mixtures generate clots that resist retraction, contain ﬁbrin-like ﬁbers and RBC aggregates. Sample clots (0.5 mL)
were cultured at 37C for 1e4 h in glass culture tubes. Whole blood clots retracted (A and B), while chitosaneGP/blood clots retracted very
little (C and D). Histology of clot samples in plastic (E and F), or parafﬁn (G and H) showed biconcave RBCs (black arrowheads) with ﬁbrin-like
ﬁbers (H, black arrows) and light blue or Fast Green-stained chitosan36 (open arrowhead) dispersed homogeneously among clumps of RBCs.
Blood smears showed chitosan-speciﬁc erythrocyte aggregates (J) compared to normal blood (I), which were not detected in GP/blood mix-
tures (data not shown). Samples were generated with sheep (A and C), human (B, D, G and H) or rabbit whole blood (E, F, I and J).of all pores was manually counted. In addition, we counted
the number of points (grid intersections) that fell within all
bone pores (P) and within the entire bone sample (B), the
latter serving as a reference volume38. Pore surface area
per reference volume (Sv in mm2/mm3) was calculated ac-
cording to the equation Sv¼ I/(B 0.01975 mm)38. Pore
volume per reference volume (Vv, in percent m3/m3) was
obtained according to the equation Vv¼P/B38. Some de-
gree of sampling bias was present in these measurements,due to the unavoidable anisotropy and non-random orienta-
tion of the osteochondral sections.
STATISTICAL ANALYSIS
To test the hypothesis that treatment affected repair, dif-
ferences in O’Driscoll histological scores were analyzed by
the ManneWhitney U test for one section per defect over
the holes (n¼ 16) and one section per defect between the
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ences were considered signiﬁcant for P exact values,
P< 0.05. The Student’s t test was used to determine
whether clot retraction was signiﬁcantly different between
chitosaneGP and normal blood clots 4 h post-solidiﬁcation,
and whether chitosaneGP/blood implants signiﬁcantly im-
proved histomorphometric and stereological variables com-
pared to blood clots alone. Correlation coefﬁcients were
obtained by multivariate analysis of covariate scatterplots
(Statistica version 6.1, Tulsa, OK) with signiﬁcance deter-
mined when P< 0.05.
Results
CHITOSANeGP SOLUTIONS STABILIZE BLOOD CLOTS
Mixing experiments were performed in order to create
hybrid chitosan blood clots that solidiﬁed within 10 min. Tri-
als with different ratios of blood and chitosaneGP solutions
revealed that homogeneous chitosaneGP/blood clots
formed most rapidly using a ratio of 1 volume chitosaneGP
to 3 volumes whole blood from rabbit, sheep, or human.
After 1 h at 37C, whole blood clots retracted up to 40%
of their original mass, were stiff and non-elastic
[Fig. 1(A,B)]. In contrast, hybrid chitosaneGP/blood clots
containing ﬁnal concentrations of 0.4% w/v chitosan and
34 mM glycerol phosphate were ﬁrm and elastic
[Fig. 1(C,D)]. Mixture of chitosan without glycerol phosphate
(pH 4.7) into whole blood resulted in unstable and brittle
clots with substantial hemolysis that was not seen in normal
clots or in chitosaneGP/blood clots (data not shown). Com-
pared to normal clots [Fig. 1(E,G)], chitosaneGP/blood
clots were comprised of a chitosan scaffold homogeneously
dispersed among clumps of red blood cells (RBCs) with his-
tologically visible ﬁbrin-like ﬁbers [Fig. 1(F,H)]. In blood
smears generated from fresh chitosaneGP/blood mixtures,
chitosan speciﬁcally mediated adhesion between RBCs
(Fig. 1, compare panels I and J). ChitosaneGP/blood clots
retracted signiﬁcantly less than the normal clots
[Fig. 1(AeD)] in three different species (P< 0.0001, Fig. 2).
EFFECT OF SURGICAL DEBRIDEMENT ON CARTILAGE REPAIR
In skeletally mature rabbits, the trochlear calciﬁed carti-
lage layer had an average thickness of 77 20 mm, some-
times attaining half the thickness of the non-mineralized
articular cartilage, which in the area of the defects had an
average thickness of 160 mm 41 mm (n¼ 6). A preliminary
study was performed to examine the effect of debridement
of the calciﬁed layer on cartilage repair. Complete debride-
ment of the calciﬁed layer to the bleeding cancellous bone
followed by marrow stimulation led to severe subchondral
bone resorption and ﬁbrous repair [Fig. 3(A,C,E)]. By
comparison, defects that were debrided into the calciﬁed
layer, drilled, and treated with chitosaneGP/blood implant
developed variable amounts of hyaline repair tissue
[Fig. 3(B,D,F)]. Based on these results, our study was con-
ducted using drilled defects that had been debrided into, but
not beyond, the calciﬁed layer [Fig. 4(A)]. Control defects
were allowed to ﬁll with bone-derived blood [Fig. 4(A), in-
set], while treated defects were ﬁlled with chitosaneGP/
blood which formed a solid implant after 7e10 min
[Fig. 4(B), Table I]. Histomorphometry of initial defects
showed that an average 40% of the cross-section of the
defect between the drill holes was covered by residual cal-
ciﬁed cartilage, the remainder of the defect consisting of
exposed subchondral bone [n¼ 3, Fig. 5(A)].EFFECT OF THE CALCIFIED LAYER AND CHITOSANeGP/
BLOOD IMPLANTS ON BONE REPAIR, AND THE INTEGRATION
AND QUALITY OF CARTILAGE REPAIR
After 8 weeks of repair, an animal-speciﬁc, bilaterally
consistent macroscopic ﬁlling was seen in the trochlear de-
fects. In 11 rabbits, bilateral defects were covered with tufts
of repair tissue over the drill holes [Fig. 4(C,D)], while in
ﬁve rabbits, both defects were completely resurfaced
[Fig. 4(E,F)]. Control repair tissue was typically white and
streaky while treated repair tissue was white and glassy.
Histological sections taken between the drill holes showed
that defects with tufts of repair tissue had persistent
calciﬁed cartilage [Fig. 6(AeD)]. In some rabbits, the control
defect between the drill holes was completely devoid of
repair tissue [Fig. 6(A,C)], while the contralateral treated
defect contained tufts of hyaline repair tissue growing
above porous bone and breaching the calciﬁed layer
[Fig. 6(B,D)].
Histomorphometry of the tissues covering the defects af-
ter 8 weeks of repair revealed that less average calciﬁed
cartilage was present compared to the initial defects,
with correspondingly less calciﬁed cartilage remaining in
treated defects both between and through the drill holes
[Fig. 5(A)]. A similar average volume of repair tissue cov-
ered the control and treated defects [Fig. 5(B)]. However,
in many control defects, the repair tissue was growing
from the drill holes and over, but not integrating with, the
defect base [Figs. 6(E,G), 7(A,B)]. An average 12% of re-
pair tissue covering the control defects between the drill
holes was detached from the base of the defect, while
only 1% of repair tissue covering treated defects was de-
tached [P< 0.05, Fig. 5(C)]. Treated defects were resur-
faced with more integrated repair tissue between the drill
holes [76% treated vs 39% control, P< 0.005, Fig. 5(C)].
After 8 weeks of repair, repair tissues in many defects
had not yet reached the edges of the defect, giving a me-
dian score of 0 for bonding with the adjacent cartilage
Fig. 2. ChitosaneGP incorporation into blood signiﬁcantly inhibits
clot retraction. ChitosaneGP/blood clots retained more volume
(P < 0.0001) after 4 h at 37C using whole blood from human
(n¼ 7), sheep (n¼ 10), and rabbit (n¼ 9).
83Osteoarthritis and Cartilage Vol. 15, No. 1Fig. 3. Development of ﬁbrous or hyaline repair following marrow stimulation depends on the extent of debridement. Bilateral trochlear defects
were generated in the knees of skeletally mature rabbits by debriding the calciﬁed cartilage layer completely and administering ﬁve microfrac-
ture holes (A) or by debriding into the calciﬁed cartilage layer and piercing four microdrill holes (B). In each rabbit, one defect was allowed to ﬁll
with bone marrow-derived blood (for example, A, inset), while the contralateral defect was ﬁlled with chitosaneGP/blood which was allowed to
clot in situ (for example, B, inset). Repair at 7e11 weeks showed that defects debrided of the calciﬁed layer had extensive subchondral bone
resorption and ﬁbrous tissue repair (C and E), while more hyaline repair was seen in defects debrided slightly into the mineralized zone with no
visible punctuate bleeding that were then drilled, and treated with chitosaneGP/blood implant (D and F). Arrows: resorbed bone. AC: articular
cartilage layer.[Fig. 6(A,B,E,F); Table II, parameter VI]. Treatment led to
repair tissue with more intense staining for collagen type
II over the drill holes [P< 0.005, Figs. 5(D), 7]. Treatment
also led to greater hyaline cartilage morphology, Toluidine
Blue staining intensity, slightly more cellularity, and highertotal O’Driscoll scores (P values: P< 0.05 to P< 0.0005,
Table II). More remarkable histological differences be-
tween treated and control repair tissues were observed
between the drill holes and these differences are summa-
rized in Table II.
84 C. D. Hoemann et al.: Chitosan blood clots elicit hyaline repairFig. 4. Appearance of defects and implant at surgery, and bilateral repair at 8 weeks post-surgery. All defects were debrided into the calciﬁed
layer with four drill holes (A) and allowed to bleed as a control (inset of A, C, and E) or treated with chitosaneGP/blood implant (B, D, and F).
Two patterns of repair were observed where bilateral defects either had tufts of tissue growing from the drill holes in 11 out of 16 rabbits (C and
D) or were completely resurfaced in ﬁve out of 16 rabbits (E and F). Treated defects had a distinct macroscopic appearance compared to
surgery-only controls. The single and double arrows indicate the areas used to generate plastic Toluidine Blue-stained sections through
and between the drill holes for histomorphometric, histological, and stereological analyses. The triple arrow indicates the region where parafﬁn
sections were generated for collagen type II immunostaining over the distal holes.TREATMENT ELICITED HYALINE REPAIR THROUGH A
MECHANISM INVOLVING BONE REPAIR AND REMODELING
Hyaline repair was frequently associated with porous,
vascularized subchondral bone [Fig. 6(D,H), open arrows;
Fig. 7(E), dotted black circles]. In the superﬁcial 250 mm of
the repaired subchondral bone plate, treatment was found
to increase the pore surface area (Sv) and pore volume
(Vv) over the holes [P< 0.005, Fig. 5(E,F)]. This effect
was partly due to the fact that in many controls, themicrodrill holes had repaired with ﬁbrous tissue instead of
bone [Fig. 7(B)]. A lack of bone repair at 8 weeks in the mi-
crodrill holes was associated with ﬁbrous or ﬁbrocartilage
repair [Fig. 7(C)]. Treatment also increased Sv and Vv be-
tween the holes (P< 0.005), consistent with the observation
that treatment elicited remodeling of the subchondral bone
plate between the drill holes at earlier time points, between
2 and 5 weeks post-surgery39. Sv correlated positively with
Vv for all 32 defects (P< 0.0001), approximately doubling in
85Osteoarthritis and Cartilage Vol. 15, No. 1Fig. 5. Histomorphometric and stereological analyses. Initial defects repaired for 1 day (xn¼ 3) were analyzed only for residual calciﬁed car-
tilage (A) while defects repaired for 8 weeks (n¼ 16) were submitted to all of the analyses (AeF). All data are given as the average standard
deviation. (A) Percent of defect width covered by residual calciﬁed cartilage was quantiﬁed between the drill holes of initial defects, and be-
tween or through the drill holes of 8 week repaired defects. (B) Cross-sectional repair tissue area over and between the holes. (C) Percent of
repair tissue covering the cross-sectional area of the defect that was integrated (white and black bars) or detached (hatched bars) from the
base of the defect. (D) Percent collagen type II staining tissue (light staining, grey or black bars; intense staining, striped bars) detected in the
total repair tissue area over the distal drill holes. Stereological analysis of the superﬁcial 250 mm region of the subchondral bone plate for (E)
bone pore surface area per reference volume (Sv), or (F) bone pore volume per reference volume (Vv). Symbols: x ¼ samples from day 1 post-
operative; *P< 0.05, **P< 0.005, and ***P< 0.0005, compared to control; #P< 0.05 for detached repair tissue compared to treated, and
##P< 0.005 for integrated repair tissue compared to control.both cases, thereby maintaining a similar pore volume to
surface area ratio. These data suggest that gross pore mor-
phology was not altered by treatment, but rather that the
pore number was increased by treatment throughout the
bone immediately below the defect. The average Sv of
the subchondral bone plate below control vs treated defects[6 vs 10 mm2/mm3, Fig. 5(E)] was in-between Sv values
previously obtained for cortical bone vs cancellous bone
(2.5 vs 20 mm2/mm3)40.
A covariate correlation analysis of all defects (n¼ 32)
revealed that the absence of calciﬁed cartilage was a signif-
icant predictor of integration of repair tissue with theFig. 6. Histology of Toluidine Blue-stained plastic sections taken from between the drill holes of bilateral defects at 8 weeks. Control defects
(A, C, E, and G) and contralateral treated defects (B, D, F, and H) are shown for the bilateral defects with tufts of repair tissue shown in
Fig. 4(C,D) (panels A through D), or the completely resurfaced bilateral defects from Fig. 4(E,F) (panels E through F). Hyaline repair was de-
ﬁned according to O’Driscoll31 as a repair tissue containing cells with a chondrocyte morphology surrounded by distinct lacunae, and more
intense Toluidine Blue staining. Subchondral bone pores associated with hyaline repair (D and H) contained blood vessels (open arrowheads).
86 C. D. Hoemann et al.: Chitosan blood clots elicit hyaline repairFig. 7. ChitosaneGP/blood implants create a repair tissue at 8 weeks that is more integrated, with more intense collagen type II expression
over porous bone. Immunohistochemistry for collagen type II is shown for repaired bilateral defects from a rabbit where the defect was com-
pletely resurfaced. Repair over former drill hole is indicated for respective defects (black arrows, upper panels), and the region under the arrow
shown at successively higher magniﬁcations directly below. In this representative control defect (A, B, and C), the drill holes had incomplete
bone repair, with a ﬁbrocartilage tissue growing over the defect which failed to attach to the bone, with somewhat lighter superﬁcial collagen
type II stain and a non-porous subchondral bone plate (A, C, and E). The contralateral chitosaneGP/blood treated defect had a homogeneous
complete repair of the drill holes with porous bone (dotted black circles, E), complete tissue integration (A and E), and a more hyaline appear-
ance with columnar cell organization and higher cell density (F).subchondral bone both over (P< 0.005) and between
microdrill holes (P< 0.01). Other predictive relationships
between variables were only observed between the drill
holes and not over the drill holes. Between drill holes, the
absence of calciﬁed cartilage predicted a higher total
O’Driscoll score (P< 0.005), while a higher bone pore sur-
face area (Sv) in the subchondral plate was a predictor of
better repair tissue integration (P< 0.005), and a higher
total O’Driscoll score (P< 0.01).
Discussion
CLOT STABILIZATION BY CYTOCOMPATIBLE CHITOSAN
SOLUTIONS
ChitosaneGP/blood clots are novel implants with
wound-healing properties originating both from wholeblood components, and the chitosan itself. Acidic chitosan
solutions and solid chitosan substrates have been previ-
ously shown to be pro-coagulatory14, by generating
a RBC thrombus16, and by promoting platelet aggregation
and degranulation15e17,41e43. Our data now extend these
observations to show that liquid mixtures of whole blood
and chitosaneGP can generate solid, homogeneous poly-
mer-reinforced hybrid clots. ChitosaneGP solutions medi-
ated erythrocyteeerythrocyte adhesion, suggesting that
the surgically implanted chitosaneGP/blood clot implants
had greater bonding between RBCs than normal clots.
The available data41,44 suggest that platelets are activated
in the hybrid chitosaneGP/blood clots, but are somehow
inhibited from fully retracting the ﬁbrin network. Clot
retraction can be inhibited by interruption of the ﬁbrine
platelet integrin receptor complex45 via blocking anti-
bodies46 or genetic defects in the platelet integrin receptor
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Histological O’Driscoll scores. Median (range)
Eight week repaired trochlear defect sections (n¼ 16)
Between drill holes Over drill holes
Untreated Treated Untreated Treated
I Chondrocyte cell morphology (0e4) 1 (1e4) 3.5 (1e4)y 2 (1e4) 4 (2e4)y
II Toluidine Blue stain (0e3) 1 (0e3) 2.5 (1e3)z 2 (1e3) 3 (1e3)*
III Surface regularity (0e3) 3 (2e3) 3 (3) 3 (2e3) 3 (3)
IV Structural integrity (0e2) 2 (0e2) 2 (1e2) 2 (1e2) 2 (1e2)
V Thickness (0e2) 0 (0e2) 0.5 (0e2) 1 (0e2) 1 (0e2)
VI Bonding with adjacent cartilage (0e2) 0 (0e1) 0 (0e2) 0 (0e2) 0 (0e1)
VII Normal cellularity (0e3) 2 (0e3) 3 (2e3)y 2 (0e3) 3 (2e3)y
VIII No chondrocyte clustering (0e2) 2 (0e2) 2 (0e2) 2 (1e2) 2 (1e2)
IX Free from degeneration in adjacent cartilage (0e3) 2 (2e3) 2 (2e3) 2 (2e3) 2 (2e3)
Total score (maximum¼ 24) 13 (4e20) 18.5 (14e21)z 17 (10e21) 19.5 (14e21)*
*P< 0.05 compared to untreated; yP< 0.005 compared to untreated; zP< 0.0005 compared to untreated.(GPIIb, GPIIIa)45,47, suggesting that chitosan may interfere
with ﬁbrineplatelet interactions. Given that chitosaneGP/
blood clots solidiﬁed after a 5e10 min delay, retracted
slightly, and contained thin ﬁbrin-like ﬁbers, it nonetheless
appears that the clotting cascade and generation of a ﬁbrin
network are part of the structural stabilization of the hybrid
chitosaneGP/blood clot.
CHITOSANeGP/BLOOD CLOTS STIMULATE CHANGES IN THE
SUBCHONDRAL BONE PLATE THAT LEAD TO HYALINE
CARTILAGE REPAIR
A bilateral rabbit cartilage repair model was developed
to study the effect of chitosaneGP/blood implants on car-
tilage repair following marrow stimulation. After 8 weeks of
repair, a similar average amount of repair tissue was
formed in control and treated defects although the repair
tissue integration and quality were signiﬁcantly improved
by treatment. In this rabbit study, as well as in our
previous ovine cartilage repair study26, chitosaneGP/blood
implants elicited a more hyaline and cellular repair
cartilage in marrow-stimulated defects compared to
marrow stimulation alone. The repair tissue in treated
rabbit defects was still somewhat heterogeneous and
was not entirely composed of hyaline cartilage, which
could be partly related to the early time point studied,
and also to the use of trochlear defects which developed
signiﬁcantly less hyaline cartilage repair than condylar
defects in sheep26. We have found that an 8-week repair
period in this particular rabbit model was a minimal yet
sufﬁcient time period needed to measure a signiﬁcant
improvement in repair over controls. Longer repair periods
in this rabbit model will allow us to characterize repair
tissue durability.
The aim of marrow stimulation is to generate access
channels for repair cells, including pluripotent bone marrow
stromal cells, to migrate into the chondral defect and possi-
bly give rise to chondrocytes and hyaline cartilage matrix. In
all drilled defects, hyaline cartilage repair was frequently
detected in areas where bone repair or remodeling gave
rise to a porous bone plate [Figs. 5(E,F), 6(B), 7(E)], while
ﬁbrous or ﬁbrocartilage tissue was principally observed in
regions of failed bone repair [Figs. 3(C), 7(B)] and in regions
of failed repair tissueebone integration [Figs. 5(C), 6(G),
7(B), Table II, between holes]. Taken together, these obser-
vations are consistent with the notion that chondral precur-
sors can gain access to the defect by regenerating or
remodeling bone. The failure of integrated repair tissue toform over large areas of calciﬁed cartilage in this study
[Fig. 6(A)], and in other studies8e10,48,49 could be partly
explained by the inability of marrow-derived repair cells to
adhere to, and migrate over, large areas of mineralized tis-
sue containing negatively charged GAG. Repair tissue was
able to form over debrided bone in controls [Fig. 5(B), 6(G),
7(B)], however, the tissue frequently failed to adhere
[Fig. 5(C)], as previously observed after resurfacing proce-
dures in rabbit6 and human patients2.
The formation of more integrated and hyaline tissue by
chitosan clot implants could be related to several mecha-
nisms. Residual chitosan clot implant adhering to trochlear
calciﬁed cartilage and bone26 could potentially provide an
adhesive surface onto which repair tissues growing from
the marrow holes could attach. Stimulation by chitosan clots
of bone remodeling between the drill holes39, and remodel-
ing and resorption of the calciﬁed cartilage layer [Figs. 5(A),
6(B)] could give direct access to the defect by marrow cells
in the bone plate, including blood microvessel pericyte
chondral progenitors50. Finally, chitosan clots stimulated
cell recruitment and transient subchondral angiogenesis
during acute repair39, which in this study, and also in our
ovine model26, led to the generation of a porous, revascu-
larized subchondral bone plate [Figs. 5(E,F), 6(D,H),
7(E)]. Cartilage repair tissue integrated with a local vascular
supply protected by bone could serve to provide progeni-
tors, oxygen and nutrients, or other marrow-derived factors
that stimulate chondrogenic proliferation, differentiation,
and hyaline matrix production.
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